Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Isopropyl Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopropyl Alcohol SCHEMBL27381930 | 1.00 | ALDH1A1 (0.86) | — | |
| Isopropyl Alcohol SCHEMBL9317726 | 1.00 | — | — | |
| Isopropyl Alcohol SCHEMBL1236799 | 1.00 | ALDH1A1 (0.86) | — | |
| Isopropyl Alcohol SCHEMBL27448530 | 1.00 | — | — | |
| Isopropyl Alcohol SCHEMBL9274890 | 0.94 | — | — | |
| Isopropyl Alcohol SCHEMBL237696 | 0.94 | — | — | |
| Isopropyl Alcohol SCHEMBL9700971 | 0.94 | — | — | |
| Isopropyl Alcohol SCHEMBL3349802 | 0.94 | — | — | |
| Isopropyl Alcohol SCHEMBL10657090 | 0.94 | ALDH1A1 (0.75) | — | |
| Isopropyl Alcohol SCHEMBL13372790 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116710476-A | Determination for fixed dose combinations | 豪夫迈·罗氏有限公司 | 2023-09-05 | — | — | CN | claimed |
| US-11691944-B2 | Solabegron zwitterion and uses thereof | B3AR THERAPEUTICS, INC. (US) | 2023-07-04 | — | — | US | claimed |
| EP-4182688-A1 | ASSAYS FOR FIXED DOSE COMBINATIONS | F. Hoffmann-La Roche AG (CH) | 2023-05-24 | — | — | EP | claimed |
| CN-113634211-B | Preparation method and equipment of diisopropyl succinate | 河北彩客新材料科技股份有限公司 | 2022-11-25 | — | — | CN | claimed |
| US-11369945-B2 | Simple single-step porous polymer monolith for DNA extraction | WOOLLEY ADAM T (US) | 2022-06-28 | — | — | US | claimed |
| US-20220177455-A1 | CRYSTAL FORMS OF A PYRIDAZINONE TRPC INHIBITOR | GOLDFINCH BIO, INC. | 2022-06-09 | — | — | US | claimed |
| WO-2022013189-A1 | ASSAYS FOR FIXED DOSE COMBINATIONS | F. HOFFMANN-LA ROCHE AG (CH) | 2022-01-20 | — | — | WO | claimed |
| CN-113634211-A | Preparation method and equipment of diisopropyl succinate | 彩客化学(沧州)有限公司 | 2021-11-12 | — | — | CN | claimed |
| US-10844004-B2 | Solabegron zwitterion and uses thereof | VELICEPT THERAPEUTICS, INC. (US) | 2020-11-24 | — | — | US | claimed |
| US-20200237654-A1 | MICROSTRUCTURE ARRAY, METHODS OF MAKING, AND METHODS OF USE | CORIUM PHARMA SOLUTIONS, INC. | 2020-07-30 | — | — | US | claimed |
| EP-1189956-B1 | POLYMER SOLUTIONS | BIOCOMPATIBLES UK LTD (GB) | 2003-07-23 | — | — | EP | claimed |
| US-20030050343-A1 | Novel potentiating compounds | OASMIA PHARMACEUTICAL AB (SE) | 2003-03-13 | — | — | US | claimed |
| JP-2003506501-A | — | — | 2003-02-18 | — | — | JP | claimed |
| WO-2002092600-A1 | RETINOL DERIVATIVES POTENTIATION OF ACTIVE SUBSTANCES BY MICELLAR PREPARATION | ARDENIA INVESTMENTS LTD. (GB) | 2002-11-21 | — | — | WO | claimed |
| EP-1189956-A1 | POLYMER SOLUTIONS | BIOCOMPATIBLES LTD. (GB) | 2002-03-27 | — | — | EP | claimed |
| WO-2001009208-A1 | POLYMER SOLUTIONS | BIOCOMPATIBLES LIMITED (GB) | 2001-02-08 | — | — | WO | claimed |
| EP-0884322-A1 | PROCESSES FOR THE PREPARATION OF ERYTHROMYCIN DERIVATIVES | Takeda Chemical Industries, Ltd. (JP) | 1998-12-16 | — | — | EP | claimed |
| US-H1334-H | Electrochemical cells with sodium as anodes with electrolyte separators of aluminates, Teflon bonded iron sulfide cathodes, in melts of sodium aluminum chloride | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1994-07-05 | — | — | US | claimed |
| US-5154991-A | Having sodium-lead alloy anode, iron disulfide cathode and Teflon-bonded, flexible alumina separator | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) | 1992-10-13 | — | — | US | claimed |
| US-4077842-A | Stabilized glucose isomerase enzyme concentrate | ENZYME BIO-SYSTEMS LTD. BOX 8000 ENGLEWOOD CLIFFS, NJ 07632 A DE CORP | 1978-03-07 | — | — | US | claimed |